Evidence map›Paper›PMID 12857856›Full record

ArticleMolecular biology of the cell2003

Intracellular Na+ controls cell surface expression of Na,K-ATPase via a cAMP-independent PKA pathway in mammalian kidney collecting duct cells.

Manlio Vinciguerra, Georges Deschênes, Udo Hasler, David Mordasini, Martine Rousselot, Alain Doucet, Alain Vandewalle, Pierre-Yves Martin, Eric Féraille

Open access · greenAbstract read
In one paragraph

Article in Molecular biology of the cell, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 61 citations in OpenAlex.

  1. Diseases caused by mutations in the NaAmerican journal of physiology. Cell physiology · 2021
    Review
  2. Article
  3. Article
  4. Salt-induced NaPflugers Archiv : European journal of physiology · 2017
    Article
  5. Coordinated Control of ENaC and Na+,K+-ATPase in Renal Collecting Duct.Journal of the American Society of Nephrology : JASN · 2016
    Review
  6. Article
  7. Article
  8. Transcriptional regulators of Na,K-ATPase subunits.Frontiers in cell and developmental biology · 2015
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Protein kinase A activation confers resistance to trastuzumab in human breast cancer cell lines.Clinical cancer research : an official journal of the American Association for Cancer Research · 2009
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Manlio VinciguerraDivision de Néphrologie, Fondation pour Recherches Médicales, CH-1211 Genève 4, Switzerland.
Georges Deschênes
Udo Hasler
David Mordasini
Martine Rousselot
Alain Doucet
Alain Vandewalle
Pierre-Yves Martin
Eric Féraille
Foundation for laboratory medicine · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the mammalian kidney the fine control of Na+ reabsorption takes place in collecting duct principal cells where basolateral Na,K-ATPase provides the driving force for vectorial Na+ transport. In the cortical collecting duct (CCD), a rise in intracellular Na+ concentration ([Na+]i) was shown to increase Na,K-ATPase activity and the number of ouabain binding sites, but the mechanism responsible for this event has not yet been elucidated. A rise in [Na+]i caused by incubation with the Na+ ionophore nystatin, increased Na,K-ATPase activity and cell surface expression to the same extent in isolated rat CCD. In cultured mouse mpkCCDcl4 collecting duct cells, increasing [Na+]i either by cell membrane permeabilization with amphotericin B or nystatin, or by incubating cells in a K(+)-free medium, also increased Na,K-ATPase cell surface expression. The [Na+]i-dependent increase in Na,K-ATPase cell-surface expression was prevented by PKA inhibitors H89 and PKI. Moreover, the effects of [Na+]i and cAMP were not additive. However, [Na+]i-dependent activation of PKA was not associated with an increase in cellular cAMP but was prevented by inhibiting the proteasome. These findings suggest that Na,K-ATPase may be recruited to the cell membrane following an increase in [Na+]i through cAMP-independent PKA activation that is itself dependent on proteasomal activity.

Indexed as

SulfonamidesAmphotericin BAnimalsCell MembraneCell Membrane PermeabilityCells, CulturedCyclic AMPCyclic AMP-Dependent Protein KinasesEnzyme ActivationEnzyme InhibitorsIntracellular FluidIonophoresIsoquinolinesKidney Tubules, CollectingMiceNystatinAmphotericin Bcardiac glycoside receptorsCyclic AMPCyclic AMP-Dependent Protein KinasesEnzyme InhibitorsIonophoresIsoquinolinesN-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamideNystatinPotassiumProtein Serine-Threonine KinasesSodiumSodium-Potassium-Exchanging ATPaseSulfonamides

Identifiers

PMID12857856
PMCPMC165668
OpenAlexW2129172715

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.